Introduction
Respiratory syncitial virus (RSV) is a member of the Paramyxoviridae family consisting of a negative-strand RNA genome in a nucleocapsid. RSV preferentially infects airway epithelial cells, causing bronchiolitis and respiratory infections (1) and can exacerbate asthma and chronic obstructive pulmonary diseases (1) . However, an effective vaccine for RSV is not yet available. Recurrent RSV infections are often observed in humans, and this is due to the failure of the hosts to raise long-lasting immunity against RSV (1) . Recent reports suggested that cell-mediated immunity, including cytotoxic T lymphocytes (CTL), natural killer (NK), and B cells, develops followed by maturation of mDCs (2) . These lymphocytes produce gamma interferon (IFN-") which orchestrates the acquired immune response to eradicate viral infection (3) . (8, 9 ) in addition to dsRNA, whereas TLR3 captures only dsRNA. Their signaling pathways partially overlap in that they converge upon the IRF3-activating kinase complex for activation of the IFN-! promoter (10) . Bronchial epithelial cells and mDCs preserve these receptors and downstream signaling pathways. mDC TLR3 particularly plays a crucial role in driving mDCs to direct CTL-and NK-inducing maturation as well as RSV infection-mediated type I IFN production (11,12).
For induction of type I IFNs and NK/CTL activation, the cytoplasmic Toll-IL-1R-homology (TIR) domain of TLR3 recruits the adaptor molecule TICAM-1 (TRIF) (13, 14) , while lipopolysaccharide (LPS) allows TLR4 to recruit the adaptor molecules TICAM-2 (TRAM) and TICAM-1 (15, 16) . Thus, TICAM-1 is the common adaptor in the pathways of TLR3 and TLR4. Both pathways activate IRF-3 and IRF-7 through a MyD88-independent pathway, resulting in IFN-! production. Extrinsic proteins are shown to antagonize IFN response (26, 27) . Nevertheless, type I IFN is induced in RSV-replicating cells through the amounts of IFN are relatively low. The envelope of RSV contains three transmembrane surface proteins, the fusion glycoprotein (F protein), G glycoprotein (G protein) and SH protein. F protein is responsible for fusion of the viral envelope with the plasma membrane of the host target cell (28) . The F protein may induce activation of NF-$B and the IFN-! promoter via TLR4 (29, 30) . In addition, the F protein of RSV serves as an agonist of TLR4 and induces proinflammatory cytokines (29) . On the other hand, the G glycoprotein (G protein) , that mediates attachment of the virus particle to the target cell (31), and SH protein is not functionally well-understood (32). Infected cells also produce a smaller secreted form of the G protein (sG protein) besides the transmembrane type G protein (33) . The RSV G protein has been implicated in altered cytokine and chemokine expression by pulmonary leukocytes (34) . Yet, there has been no report on the RSV surface proteins that affect cytoplasmic IFN-inducing events. Accordingly, no report has mentioned the possible association between the RSV G/SH proteins and the TLR pathways in RSV infection.
Here we discovered a role of the RSV G protein in mDC IFN response. This protein inhibits the TLR3/4-mediated IFN-! promoter activation through RSV-host cell interaction. A possible target for the G protein-attachment to cells is the TICAM-1 pathway, thereby TLR3/4-mediated type I IFN induction being prohibited. The RSV G For human immature DC preparation, CD14-positive monocytes were prepared from huPBMC by using MACS system (Miltenyi Biotec, Gladbach, Germany) with anti-human CD14 mAb-conjugated microbeads and kept in RPMI-1640 (Invitrogen) containing 10% FCS, 500 IU/ml human GM-CSF, 100 IU/ml human IL-4 (Prepro Tech, London UK) and antibiotics for 6 days. Morphological changes were examined by phase contrast microscopy (Olympus IX-70, Tokyo Japan).
Flow-activated cell-sorting (FACS) cytometric analysis of cell surface antigens
FACS methods were described previously (35) . Briefly, cells were suspended in PBS containing 0.1% sodium azide and 1% BSA (FACS buffer) and incubated for 30 min at 4 °C with relevant or control mAbs, followed by FITC-labeled anti-mouse IgG F(ab') 2 . In some experiments, cells were directly stained with FITC-labeled anti-RSV polyclonal Ab.
Cells were washed, and their fluorescence intensities were measured by FACS.
Determination of human TNF-# and IFN-! level
Quantitative PCR and ELISA were used for this purpose. Culture media were centrifuged to remove cell debris and the supernatants were stored at -80 ˚C until the assay.
The level of secreted human TNF-# or IFN-! in the culture medium was determined with enzyme-linked immunosorbent assay (ELISA) kits (Amersham Pharmacia and FUJIREBIO, Tokyo Japan). The detection limits of human TNF-# and IFN-! were < 5 pg/ml and < 2.5 U/ml, respectively. Quantitative PCR and the primers for this assay were performed as described previously (36) .
RSV sequences and plasmid construction
Total RNA from RSV2177 infected HEp-2 cells was extracted with RNeasy mini kit (Qiagen). After DNase treating, 1 µg of total RNA was incubated at 70 ˚C for 5 min, kept on ice for 2 min, and reverse transcription was performed with MMLV-reverse transcriptase (Promega, WI) at 37 ˚C for 90 min followed by PCR. Detection of RSV subgroup was performed by PCR with subgroup specific primer sets (37) 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Plasmid transfection and luciferase assay
A luciferase reporter plasmid, pISRE-Luc, was from Stratagene (Stratagene, CA), pELAM-Luc reporter plasmid was constructed as referred in the ref (29) . pRL-TK vector was from Promega, WI. A plasmid for human TLR3 and TICAM-1 expression was described previously (13) . Plasmids for human TLR4, MD-2, and CD14 expression were kindly provided from Dr. K Miyake (the University of Tokyo, Tokyo), that for TBK1 expression from Dr. M Nakanishi (the Nagoya City University, Nagoya) and that for IKK% incubation, cells were lysed with lysis buffer and the assay was performed using dual luciferase reporter assay system. Fold induction against the control medium is indicated.
Immunoprecipitation, SDS-PAGE and western blotting
Cells were washed in PBS (pH 7.4), and solubilized with 100 µl of 1% (v/v) Triton X-100 containing 137 mM NaCl, 2 mM EDTA, and 1 mM PMSF. After centrifugation (10,000 g for 10 min), proteins in cell lysate or culture supernatant were immunoprecipitated with anti-Flag mAb. Immunoprecipitants were washed and eluted with Flag peptide. The eluted samples were heated or non-heated, and were subjected to SDS-PAGE under reducing or non-reducing conditions. Proteins were transferred onto nylon membranes. The membranes were incubated with 10 % skimmed milk containing 5% goat serum for 30 min at room temperature, followed by the addition of anti-Flag pAbs.
One hour later, the membranes were washed extensively with PBS containing 0.5% Tween 20, and then incubated with 5 µg of HRP-conjugated goat anti-rabbit IgG antibody for 1 h at 37 ˚C. Following second incubation, the membranes were washed with PBS-Tween 20 and proteins were detected with an ECL chemiluminescence kit (Amersham Biosciences).
Endoglycosidase digestion
Protein samples were made up to a final concentration of either 100 mM Tris-HCl (pH 8.6), 0.1% SDS, 1 % NP-40, or 50 mM sodium citrate (pH 5.0), 0.5 % SDS, and incubated at 37 ˚C for 14 h with Endoglycosidase F (EndoF) (Takara) or Endoglycosidase H (Endo H) (Seikagaku corporation, Tokyo Japan), respectively, as previously reported (38) . The samples were analyzed on SDS-PAGE under reducing and non-reducing conditions.
RSV treatment of human cells
Human cells (mDC, HEK293 cells) were transfected with pGV-E2/huELAM (ELAM promoter-linked firefly luciferase) or pISRE-Luc (ISRE promoter-linked firefly luciferase), and phRL-TK (thymidin kinase with renilla luciferase). The last one is the internal control. 
Results

Immune responses induced in human DCs by RSV stimulation
DCs in the respiratory tract play important roles in the immune response against RSV infection. Human mDCs prepared from three healthy donors were incubated with RSV at MOI = 0.5. Viral proteins were detected on the mDC surface within 24 h and kept expressed over 48 h using anti-RSV polyclonal Abs by FACS analysis (Fig. 1A) .
Thus, human mDCs are susceptible to RSV of this subgroup B isolate. Fig. 2A) . In contrast, the TNF-# was somehow kept to be constant >12 h in inactive RSV-stimulated mDCs (Fig. 2B ).
We consistently found that IFN-inducible genes were barely up-regulated by function of UV-irradiated RSV even after 6 h (not shown) and 24 h post stimulation (Fig. 2C) .
IFN-inducible genes were up-regulated only when mDCs were challenged with high doses of live RSV after 12 h. According to the ~4 h mRNA levels and 24 h ELISA results, RSV-mediated robust IFN induction is the replication-dependent event.
RSV inhibits virus-cell contact-mediated IFN-! induction
UV-inactivated RSV induced TNF-# but barely induced IFN-! in the early-phase of mDCs. We asked what causes the impotent production of IFN-! in response to the external stimulation of RSV. We tested the reporter-activating abilities of RSV using the ELAM (for NF-$B) and ISRE (for IFN-!) reporter assays in HEK293 cells. Neither of the promoters was activated in response to UV-irradiated RSV at the indicated time points (Fig. 3A,B) . Live RSV on the other hand prominently activated ISRE by ~24 h p.i. (Fig. 3B) and ELAM >12 h p.i. (Fig. 3A) . These activation was not due to contaminating LPS since the HEK293 cells did not express TLR4 (Fig. 3A,B) . The RSV replication-dependent events will markedly happen >12 h p.i.. 3C,D) . ELAM promoter activation was observed in response to live and UV-inactive RSV to a similar extent (Fig. 3C) . However, virtually no ISRE activation was detected under this setting (Fig. 3D) . Both live and UV-irradiated RSV dose-dependently inhibited ISRE promoter activation by poly I:C in terms of TLR3 signaling (Fig. 4B) . We confirmed the suppression of IFN-! induction by RSV in mDCs. IF'-! protein production by LPS or poly I:C (determined 24 h p.i.) was also dose-dependently inhibited by UV-irradiated RSV in mDCs (Fig. 4C) . Function-neutralizing studies were performed using polyclonal Abs against RSV envelope proteins. We set the conditions where PolyI:C induced activation of the ISRE promoter in HEK cells and this activation was partly inhibited in response to live or UV-irradiated RSV that was administered for virus-cell contact (Fig. 4D) . A typical result is shown in Fig. 4D , where the pAb against RSV abrogated RSV-dependent inhibition of ISRE promoter activation. This implies that the virus-cell contact due to a RSV-exposing factor inhibits IFN-! promoter activation in host cells.
Since the RSV F protein does not activate TLR3, we used the TLR3/poly I:C system in the following inhibition experiments.
RSV G protein is surface-expressed to inhibit the IFN-! pathway
The question is what factor of the RSV envelope proteins participates in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 (Fig. 5A) . We confirmed protein expression in HEK293 cells using SDS-PAGE and Western blotting with an anti-Flag antibody (Fig. 5B) . Under reducing conditions, the F, G and sG proteins were detected on the blot at their expected molecular masses (Fig. 5B) . Under non-reducing conditions, all of these proteins tended to form multimers. In particular, the SH and F proteins formed multimers, that were partially dissociated upon heating and reduction (Fig. 5B) , consistent with a previous report (28) . The F, SH and G proteins, but not sG proteins, were N-glycosylated and no high mannose was detected on these proteins (data not shown). Susceptibility of these proteins to glycosidases suggested that these proteins are expressed naturally on HEK293 cells. In addition, a soluble form of the G protein of 48 kDa with no high mannose or N-linked sugars was detected in the supernatant of the cells (Fig. 5C ), consistent with a previous notion (33) .
Cells were transfected with the indicated expression plasmid, together with TLR3-expressing plasmid and the reporter plasmids. Then, the cells were stimulated with poly I:C and afer 6 h the ISRE reporter activity was measured. G protein derivatives showed a weak ability (usually ~20%) to suppress the polyI:C-mediated ISRE reporter activity as compared with the vector transfectant (Fig. 6A) . With the exception of the G protein, polyI:C-dependent ISRE activation was not affected by the expression of the RSV envelope proteins (Fig. 6A) . The result was reproducible under the conditions where proteins were expressed to similar levels. Overexpressing RSV soluble G (sG) protein appears to externally inhibit the TLR3-mediated IFN-!-inducing event.
Since the sG protein maintained its inhibitory effect, we examined the ISRE inhibition by increasing doses of RSV sG protein using the TLR3 or TLR4 system. The 
Exogenously-added RSV G protein suppresses IFN-! production in mDCs
It remained undetermined whether the extrinsic G protein physiologically controls mDC function. We determined IFN-! production in mDCs by stimulation with sG protein.
The sG-mediated suppression of IFN production was endorsed with mDCs stimulated with polyI:C or LPS using ELISA (Fig. 7A) . Finally, the purified F-protein-mediated IFN-! production was also blocked by RSV-G protein (Fig. 7B ).
Using the early phase IFN-! mRNA determination assay by quantitative PCR ( Fig. 2A) ,
we checked whether exogenously-added sG protein has an ability to inhibit (Fig. 8B) . UV-irradiated MV did not inhibit ISRE activation in terms of all the transfected constructs (Fig. 8A) . IKK%/TBK-1-mediated ISRE-response was not affected by the sG protein added, and rather increased by stimulation with UV-irradiated RSV (data not shown), although the latter reason as yet unknown. Hence, we can conclude that the sG protein selectively inhibits the TICAM-1 signaling pathway upstream of the IRF-3 kinases, but not the RIG-I/MDA5 pathway. This issue was confirmed using TICAM-1-and MAVS-silencing HeLa cells made by the RNAi technology (Matsumoto M., and Seya T., unpublished data).
Discussion
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